Winslow Evans & Crocker’s QIAGEN NV QGENF Stock Holding History
Bought
Maintained
Sold
Other funds holding QGENF
BJCM
PVI
GAM
BG
Winslow Evans & Crocker's QGENF Position: Q1 2017 in Review
Winslow Evans & Crocker sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 1,430 shares — an estimated $40.1K sold.
Winslow Evans & Crocker first reported a position in QGENF in Q4 2015 and held it in 5 quarters. The position peaked at $108K in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.
- Winslow Evans & Crocker reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
- Winslow Evans & Crocker sold 1,430 QIAGEN NV shares in Q1 2017, an estimated $40.1K.
- Winslow Evans & Crocker first reported a position in QIAGEN NV in Q4 2015 and held it in 5 quarters.
- Winslow Evans & Crocker's QIAGEN NV position peaked at $108K in Q4 2015.
- 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.
Based on Winslow Evans & Crocker's 13F filing for Q1 2017, filed 14 Apr 2017.